M Lenhard
- Co-authors
- K FrieseSabine WeckbachUwe HasbargenKonstantin NikolaouT. JohnsonNina DitschSibylle LoiblDoris Mayr
- Topics
- Cancer Risks and Factors (5 papers)Breast Cancer Treatment Studies (3 papers)Cancer Treatment and Pharmacology (2 papers)
- Partner nations
- GermanyNetherlandsBelgium
In The Last Decade
M Lenhard
12 papers receiving 101 citations
Peers
Comparison fields: 5 of 40
- Oncology 40
- Surgery 26
- Cancer Research 23
- Molecular Biology 21
- Pediatrics, Perinatology and Child Health 18
Countries citing papers authored by M Lenhard
This map shows the geographic impact of M Lenhard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Lenhard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Lenhard more than expected).
Fields of papers citing papers by M Lenhard
This network shows the impact of papers produced by M Lenhard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Lenhard. The network helps show where M Lenhard may publish in the future.
Co-authorship network of co-authors of M Lenhard
This figure shows the co-authorship network connecting the top 25 collaborators of M Lenhard. A scholar is included among the top collaborators of M Lenhard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Lenhard. M Lenhard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | Dose-dense intensified sequential versus conventionally-dosed anthracycline and taxane-containing neoadjuvant therapy in patients with inflammatory breast cancer. | 10 |
| 3 | Retinoid X receptor alpha (RXRα) and peroxisome proliferator-activated receptor gamma (PPARγ) expression in breast cancer: an immunohistochemical study. | 19 |
| 4 | 4 | |
| 5 | 5 | |
| 6 | 10 | |
| 7 | 313 Patients with breast cancer during pregnancy – a prospective and retrospective registry (GBG-20 / BIG02-03) | 1 |
| 8 | 28 | |
| 9 | 2 | |
| 10 | 5 | |
| 11 | 4 | |
| 12 | 1 | |
| 13 | 0 | |
| 14 | 0 | |
| 15 | 0 | |
| 16 | 13 |
About M Lenhard
M Lenhard is a scholar working on Oncology, Otorhinolaryngology and Cancer Research, having authored 16 papers that have together received 103 indexed citations. Recurring topics across this work include Cancer Risks and Factors (5 papers), Breast Cancer Treatment Studies (3 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Cancer Research (23 citations), Oncology (40 citations) and Obstetrics and Gynecology (9 citations). M Lenhard has collaborated with scholars based in Germany, Netherlands and Belgium. Frequent co-authors include K Friese, Sabine Weckbach, Uwe Hasbargen, Konstantin Nikolaou, T. Johnson, Nina Ditsch, Sibylle Loibl, Doris Mayr, Gϋnter von Minckwitz and Antonis Makrigiannakis. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and European Journal of Cancer Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.